See every side of every news story
Published loading...Updated

Hydroxyurea may help ease sleep issues in children: Study

Summary by Sickle Cell Disease News
Hydroxyurea, an approved medication to reduce the frequency of pain crises associated with sickle cell disease (SCD), may ease sleep-disordered breathing in children, perhaps by reducing inflammation, according to a study conducted at St. Jude Children’s Research Hospital, in Memphis. “Hydroxyurea therapy was associated with improved breathing while sleeping and improved inflammatory markers,” Zachary Abramson, MD, a radiologist at the St. Jude …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sickle Cell Disease News broke the news in on Thursday, May 8, 2025.
Sources are mostly out of (0)